Marcelo A. Nobrega

University Of Chicago

$13,690,128

Attributed

$23,731,778

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY2007–25

$5M$3.8M$2.5M$1.3M$0

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$31,506,933 · 17

By mechanism

R01$16,277,928 · 7

U19$12,869,612 · 7

R33$1,514,840 · 1

R21$844,553 · 2

Top collaborators

Most similar at University Of Chicago

Same institution · by research overlap

Elizabeth M McNally$39,500,544
Carole Ober$39,433,167
Anne I. Sperling$25,843,318
Charles M Rudin$26,521,794
Chuan He$53,119,947

Others in their field

Top investigators on “Genes”

David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
Richard A Gibbs · Baylor College Of Medicine$338,750,128
Barton F Haynes · Duke University$304,076,400
Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
Richard K. Wilson · Washington University$195,881,965

Research focus

GenesEnhancersMolecularPhenotypeGene ExpressionLinkIn VivoCellsGeneticVariantGenomicsGenome Wide Association StudyMapsPlayGenomeIn VitroTissuesTranscriptome SequencingAffectRegulatory ElementGenome-WideMutationGenetic VariantCode

Grant awards (57)

Integrated genetic, omic, and immunologic studies to identify endotypes and novel drug targets for asthma and allergic diseases$1,392,038

Admin-Core-001$47,318

U19 · FY2025 · AI

Integrated genetic, omic, and immunologic studies to identify endotypes and novel drug targets for asthma and allergic diseases$1,441,202

Gene Discovery in Asthma and Allergic Diseases$292,167

U19 · FY2024 · AI

Integrated genetic, omic, and immunologic studies to identify endotypes and novel drug targets for asthma and allergic diseases$292,167

U19 · FY2024 · AI

Admin-Core-001$101,872

U19 · FY2024 · AI

Integrated genetic, omic, and immunologic studies to identify endotypes and novel drug targets for asthma and allergic diseases$1,797,510

U19 · FY2023 · AI

(Epi)Genomics Core$869,350

U19 · FY2023 · AI · contact PI

Cardiomyopathy Genomes Project$575,272

R01 · FY2023 · HL

Integrated genetic, omic, and immunologic studies to identify endotypes and novel drug targets for asthma and allergic diseases$1,460,586

U19 · FY2022 · AI

Cardiomyopathy Genomes Project$575,272

R01 · FY2022 · HL

(Epi)Genomics Core$572,437

U19 · FY2022 · AI · contact PI

Integrated genetic, omic, and immunologic studies to identify endotypes and novel drug targets for asthma and allergic diseases$1,391,652

U19 · FY2021 · AI

Cardiomyopathy Genomes Project$598,176

R01 · FY2021 · HL

(Epi)Genomics Core$527,263

U19 · FY2021 · AI · contact PI

Cardiomyopathy Genomes Project$37,741

R01 · FY2021 · HL

Cardiomyopathy Genomes Project$650,303

R01 · FY2020 · HL

Cardiomyopathy Genomes Project$589,772

R01 · FY2019 · HL

Cardiomyopathy Genomes Project$52,127

R01 · FY2019 · HL

Cardiomyopathy Genomes Project$535,868

R01 · FY2018 · HL

Functional Assays to Screen Genomic Hits$496,520

R33 · FY2018 · HL · contact PI

Functional Genomics of IL-33 expression and asthma risk$708,574

R01 · FY2017 · HL

Cardiomyopathy Genomes Project$535,868

R01 · FY2017 · HL

Endocardial Pathways Regulated by Tbx20$529,033

R01 · FY2017 · HL · contact PI

Functional Assays to Screen Genomic Hits$505,052

R33 · FY2017 · HL · contact PI

Functional Genomics of IL-33 expression and asthma risk$694,773

R01 · FY2016 · HL

Cardiomyopathy Genomes Project$543,593

R01 · FY2016 · HL

Endocardial Pathways Regulated by Tbx20$536,231

R01 · FY2016 · HL · contact PI

Functional Assays to Screen Genomic Hits$513,268

R33 · FY2016 · HL · contact PI

Transcriptional Control of Cardiac Conduction System Function by T-box Genes$487,525

R01 · FY2016 · HL

Functional Genomics of IL-33 Expression and Asthma Risk$54,063

R01 · FY2016 · HL

Functional Genomics of IL-33 expression and asthma risk$689,409

R01 · FY2015 · HL

Cardiomyopathy Genomes Project$557,218

R01 · FY2015 · HL

Endocardial Pathways Regulated by Tbx20$532,696

R01 · FY2015 · HL · contact PI

Transcriptional Control of Cardiac Conduction System Function by T-box Genes$487,822

R01 · FY2015 · HL

Functional Assays to Screen Genomic Hits$229,428

R21 · FY2015 · HL · contact PI

Functional Genomics of IL-33 expression and asthma risk$716,340

R01 · FY2014 · HL

Endocardial Pathways Regulated by Tbx20$564,506

R01 · FY2014 · HL · contact PI

Transcriptional Control of Cardiac Conduction System Function by T-box Genes$498,996

R01 · FY2014 · HL

Functional follow-up of the association between TCF7L2 and T2D$381,234

R01 · FY2014 · DK · contact PI

Functional Assays to Screen Genomic Hits$198,372

R21 · FY2014 · HL · contact PI

Transcriptional Control of Cardiac Conduction System Function by T-box Genes$492,151

R01 · FY2013 · HL

Functional follow-up of the association between TCF7L2 and T2D$367,891

R01 · FY2013 · DK · contact PI

Transcriptional Control of Cardiac Conduction System Function by T-box Genes$585,763

R01 · FY2012 · HL

Functional follow-up of the association between TCF7L2 and T2D$395,234

R01 · FY2012 · DK · contact PI

Dissecting of the Tbx20 Regulatory Network$436,833

R01 · FY2010 · HL · contact PI

Generation and in vivo validation of cis-regulatory maps in eukaryotic genomes$494,093

R01 · FY2009 · HG · contact PI

Dissecting of the Tbx20 Regulatory Network$406,929

R01 · FY2009 · HL · contact PI

Generation and in vivo validation of cis-regulatory maps in eukaryotic genomes$479,819

R01 · FY2008 · HG · contact PI

In vivo reagents to identify functional noncoding sequences in the TCF7L2 locus$263,253

R21 · FY2008 · DK · contact PI

Generation and in vivo validation of cis-regulatory maps in eukaryotic genomes$486,803

R01 · FY2007 · HG · contact PI

In vivo reagents to identify functional noncoding sequences in the TCF7L2 locus$153,500

R21 · FY2007 · DK · contact PI